Tredje AP fonden Has $1.57 Million Holdings in The Clorox Company (NYSE:CLX)

Tredje AP fonden trimmed its holdings in The Clorox Company (NYSE:CLX - Free Report) by 50.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,664 shares of the company's stock after selling 9,664 shares during the period. Tredje AP fonden's holdings in Clorox were worth $1,570,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox in the third quarter worth $27,000. Continuum Advisory LLC lifted its stake in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc acquired a new stake in shares of Clorox in the fourth quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter worth $36,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of CLX traded up $0.45 during trading hours on Wednesday, hitting $145.33. The stock had a trading volume of 1,105,666 shares, compared to its average volume of 1,215,083. The company's fifty day moving average is $153.71 and its two-hundred day moving average is $160.08. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The stock has a market capitalization of $17.90 billion, a price-to-earnings ratio of 39.71, a P/E/G ratio of 2.62 and a beta of 0.45.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company posted $2.16 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.36%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CLX. DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 4th. Barclays increased their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, Clorox has an average rating of "Hold" and an average price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.